More tools:Markets·Screener·Research·Chat

Vir Biotechnology, Inc. Common Stock (VIR) Financial Statements

Vir Biotechnology, Inc. Common Stock
SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
FIGI BBG00H2QQ8V2
XNAS · usd
10.76▼ 0.42 (-3.80%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close11.18
Day's Range10.99 – 11.28
52-Week Range4.75 – 11.94
Volume1.6M
Avg Volume1.7M
Share Statistics
Shares Outstanding
Employees367
ExchangeXNAS
Listed2019-10-11
Share count as of July 29, 2026
Loading Income Statement…
Key questions about Vir Biotechnology, Inc. Common Stock (VIR)
What is Vir Biotechnology, Inc. Common Stock's Market Cap?
Vir Biotechnology, Inc. Common Stock's Market Cap is $1.8B, based on as-reported figures from SEC (XBRL) filings.
What is Vir Biotechnology, Inc. Common Stock's Enterprise Value?
Vir Biotechnology, Inc. Common Stock's Enterprise Value is $1.3B, based on as-reported figures from SEC (XBRL) filings.
What is Vir Biotechnology, Inc. Common Stock's Price / Sales?
Vir Biotechnology, Inc. Common Stock's Price / Sales is 6.0×, based on as-reported figures from SEC (XBRL) filings.
What is Vir Biotechnology, Inc. Common Stock's EV / Revenue?
Vir Biotechnology, Inc. Common Stock's EV / Revenue is 4.3×, based on as-reported figures from SEC (XBRL) filings.
What is Vir Biotechnology, Inc. Common Stock's EV / EBITDA?
Vir Biotechnology, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Vir Biotechnology, Inc. Common Stock's Revenue (TTM)?
Vir Biotechnology, Inc. Common Stock's Revenue (TTM) is $303.2M, based on as-reported figures from SEC (XBRL) filings.
What is Vir Biotechnology, Inc. Common Stock's Net Income (TTM)?
Vir Biotechnology, Inc. Common Stock's Net Income (TTM) is -$251.7M, based on as-reported figures from SEC (XBRL) filings.
What is Vir Biotechnology, Inc. Common Stock's EBITDA?
Vir Biotechnology, Inc. Common Stock's EBITDA is -$268.7M, based on as-reported figures from SEC (XBRL) filings.
What is Vir Biotechnology, Inc. Common Stock's Diluted EPS (TTM)?
Vir Biotechnology, Inc. Common Stock's Diluted EPS (TTM) is -1.49, based on as-reported figures from SEC (XBRL) filings.
What is Vir Biotechnology, Inc. Common Stock's EBITDA Margin?
Vir Biotechnology, Inc. Common Stock's EBITDA Margin is -88.6%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenues:
Total revenues
YoY growth+19582.5%-101.0%+417.8%-89.9%
Operating expenses:
Cost of revenue—
Research and development
Selling, general and administrative
Restructuring, long-lived assets impairment and related charges, net
Total operating expenses
% of revenue69.3%-456072.4%174.8%72367.9%
Income (loss) from operations
% of revenue30.7%456172.4%-74.8%-72267.9%
Other income:
Change in fair value of equity investments
Interest income
Other (expense) income, net
Total other income
Income (loss) before provision for income taxes
Provision for income taxes
Net income (loss)——
% of revenue33.5%433431.0%——
Net income (loss) per share, basic (in USD per share)—
Net income (loss) per share, diluted (in USD per share)—